WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time.
Shared 1 week ago
22 views
Shared 1 week ago
14 views
Shared 1 week ago
6 views
Shared 1 week ago
13 views
Shared 3 weeks ago
26 views
Shared 3 weeks ago
51 views
Shared 5 months ago
26 views
Shared 5 months ago
19 views
Shared 5 months ago
29 views
Shared 5 months ago
13 views
Shared 7 months ago
135 views
Shared 11 months ago
149 views
Shared 11 months ago
232 views
Shared 11 months ago
192 views
Shared 11 months ago
95 views
Shared 11 months ago
74 views
Shared 11 months ago
37 views
Shared 1 year ago
204 views
Shared 1 year ago
57 views
Shared 1 year ago
170 views
Shared 1 year ago
360 views
Shared 1 year ago
108 views
Shared 1 year ago
50 views
A Global Village for Global Impact: Talk with Michael Altorfer, CEO of the Swiss Biotech Association
Shared 1 year ago
63 views
Shared 1 year ago
61 views
Shared 3 years ago
34 views
Shared 3 years ago
112 views
Shared 3 years ago
49 views
Shared 3 years ago
57 views
Shared 3 years ago
13 views
Shared 3 years ago
34 views
Shared 3 years ago
12 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy (Christopher Missling)
Shared 3 years ago
193 views
Shared 3 years ago
10 views
Shared 3 years ago
60 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy Adrian Newman-Tancredi
Shared 3 years ago
12 views
Shared 3 years ago
41 views
Shared 3 years ago
48 views
Shared 3 years ago
25 views
Shared 3 years ago
8 views
Shared 3 years ago
13 views
Shared 3 years ago
13 views
Shared 3 years ago
8 views
Shared 3 years ago
35 views